JP2023063270A - ２－ヘテロアリールアミノキナゾリノン誘導体からなる医薬 - Google Patents
２－ヘテロアリールアミノキナゾリノン誘導体からなる医薬 Download PDFInfo
- Publication number
- JP2023063270A JP2023063270A JP2022169222A JP2022169222A JP2023063270A JP 2023063270 A JP2023063270 A JP 2023063270A JP 2022169222 A JP2022169222 A JP 2022169222A JP 2022169222 A JP2022169222 A JP 2022169222A JP 2023063270 A JP2023063270 A JP 2023063270A
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- alkyl
- cyano
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021173154 | 2021-10-22 | ||
| JP2021173154 | 2021-10-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023063270A true JP2023063270A (ja) | 2023-05-09 |
| JP2023063270A5 JP2023063270A5 (enExample) | 2025-10-28 |
Family
ID=86270258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022169222A Pending JP2023063270A (ja) | 2021-10-22 | 2022-10-21 | ２－ヘテロアリールアミノキナゾリノン誘導体からなる医薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2023063270A (enExample) |
-
2022
- 2022-10-21 JP JP2022169222A patent/JP2023063270A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2870203T3 (es) | Compuesto derivado tricíclico, método para prepararlo y composición farmacéutica que comprende el mismo | |
| JP7038414B2 (ja) | ムスカリン性アセチルコリンレセプターｍ４のポジティブアロステリック調節因子 | |
| EP3133075B1 (en) | Fused heterocyclic compound | |
| JP6965478B2 (ja) | ２−アミノキナゾリノン誘導体 | |
| EP3287454B1 (en) | Heterocyclic compound | |
| KR20170095881A (ko) | 베타―세크레타제의 ２,３,４,５―테트라히드로피리딘―６―아민 및 ３,４―디히드로―２ｈ―피롤―５―아민 화합물 억제제 | |
| JP2013508350A (ja) | ガンマ−セクレターゼモジュレーターとしての新規なヘテロアリールイミダゾールおよびヘテロアリールトリアゾール | |
| CA2871453A1 (en) | Quinazolinedione derivative | |
| CN108341819B (zh) | 磷酸二酯酶抑制剂及其用途 | |
| WO2019151269A1 (ja) | 複素環化合物 | |
| JP6996032B1 (ja) | ２－ヘテロアリールアミノキナゾリノン誘導体 | |
| US11401261B2 (en) | 2-heteroaryl aminoquinazolinone derivative | |
| CN116601153A (zh) | 作为nav1.8抑制剂的含氮2,3-二氢喹唑啉酮化合物 | |
| WO2021149767A1 (ja) | ヘテロ環誘導体 | |
| JP2023063270A (ja) | ２－ヘテロアリールアミノキナゾリノン誘導体からなる医薬 | |
| CN116848115B (zh) | Wnt通路抑制剂化合物 | |
| HK40082180A (en) | 2-heteroarylaminoquinazolinone derivative | |
| WO2016012384A1 (en) | Trifluormethyloxazine amidines as bace1 inhibitors | |
| JP2022132187A (ja) | ２－アミノキナゾリノン誘導体からなる医薬 | |
| CA2927152C (en) | Phenyl linked quinolinyl modulators of ror-gamma-t | |
| WO2015132141A1 (en) | 1,3-oxazine-2-amine derivatives acting as bace inhibitors for the treatment of alzheimer's disease | |
| HK40067930A (en) | 2-aminoquinazolinone derivative | |
| JP2020011902A (ja) | 縮環ピロール誘導体およびその医薬用途 | |
| WO2021020363A1 (ja) | 複素環化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20230728 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20230904 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251020 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251020 |